Showing results (611-620 of 672) with videos related to
Sort By:
Pageof 68
British Journal of Haematology|May 27, 2005
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Bronwen Shaw, Simona Iacobelli, et al.The Journal of Chemical Physics|May 4, 2026
Dynamics of coalescence in hyperquenched glassy water probed by x-raysJohannes Giebelmann, Tobias Eklund, Christina M Tonauer, et al.Leukemia|February 23, 2011
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemiaC Craddock, M Labopin, S Pillai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remissionMichael G Kiehl, Ludwig Kraut, Rainer Schwerdtfeger, et al.Haematologica|July 22, 2008
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantationFrancis Ayuk, José A Perez-Simon, Avichai Shimoni, et al.British Journal of Haematology|September 13, 2021
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMTAvichai Shimoni, Marie Robin, Simona Iacobelli, et al.Bone Marrow Transplantation|August 6, 2003
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)A R Zander, N Kröger, M Schleuning, et al.Bone Marrow Transplantation|June 11, 2003
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factorH G Sayer, M Kröger, J Beyer, et al.British Journal of Haematology|July 28, 2015
Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow TransplantationArgiris Symeonidis, Anja van Biezen, Liesbeth de Wreede, et al.Journal of Experimental & Clinical Cancer Research : CR|January 12, 2022
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancerCarmela Ferri, Anna Di Biase, Marco Bocchetti, et al.Pageof 68